Eisai R&D Management Co., Ltd., a subsidiary of Eisai Co., Ltd., is a company headquartered in Bunkyo, Japan. The firm engages in research and development of pharmaceuticals.

Korea Research Institute of Bioscience and Biotechnology (KRIBB) is a government research institute in Daejeon, South Korea. It is dedicated to biotechnology research across a broad span of expertise, from basic studies for the fundamental understanding of life phenomena to applied studies such as drug discovery, novel biomaterials, integrated biotechnology and bioinformation.

National University Corp. Tokyo Medical & Dental University is a private company headquartered in Japan that operates as an national educational institution for dentistry.

Institute of Laboratory Animal Science, a subsidiary of University of Zurich, is a Swiss company located in Schlieren that provides research, services and teaching in translational and basic research.

Shandong Qilu Stem Cells Engineering Co. Ltd. operates a cord blood bank. The firm offers stem cell clinical research and technology development, and umbilical cord blood stem cell preservation services. The company was founded in July 2004 and is headquartered in Jinan, China.

McLean Hospital was founded on Feb. 25, 1811, through a charter granted by the Massachusetts Legislature for the “Massachusetts General Hospital Corporation.” From its inception, the Corporation intended to treat both physical and mental illnesses, with a separate facility for each. Fundraising campaigns were held between 1812 and 1816, and a majority of the contributors earmarked their donations for the establishment of a facility to treat mental illnesses. McLean Hospital is dedicated to improving the lives of people and families affected by psychiatric illness. McLean Hospital is a comprehensive mental health care facility committed to providing a full range of high quality, cost effective, mental health services. At McLean Hospital, their staff, faculty, volunteers and supporters are dedicated to improving the lives of people and families affected by psychiatric illness. As the largest psychiatric affiliate of Harvard Medical School, McLean has been meeting the needs of individuals and families with psychiatric illness since their founding in 1811. McLean Hospital's staff of more than 1,900 caring and compassionate individuals are each dedicated to improving the lives of people living with mental illness and their families. McLean Hospital is an affiliate of Harvard Medical School and a member of Partners Healthcare. McLean Hospital is the largest psychiatric teaching facility of Harvard Medical School.

Guangzhou Dakang Gene Technology Co., Ltd., established on 2018-09-17, The scope of business includes the development of human gene diagnosis and treatment technology;Human stem cell technology development and application;R&D and application of cell technology;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Health Consulting Services(Does not include medical services);Medical Research and Experimental Development;Information Technology Consulting Services;New material technology research and development;Biochemical product technology research and development;New material technology promotion service;Research and development of bio-based materials technology;Sales of Class II Medical Devices;Sales of Class I Medical Devices;Consulting and planning service;Computer System Services;software development;Network technology service;Blockchain technology related software and services;internet sales(Except for products that require a license for sale);Cosmetics Retail;Cosmetics Wholesale;Sales of hygiene products and single-use medical products;Inspection and testing service;medical service;Drug Clinical Trial Services;Class III medical device business;Technology Import and Export;Cosmetic production;

Guangzhou Zhili Medical Diagnostic Technology Co., Ltd., established on 2019-04-30, Business scope includes medical research and experimental development;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Natural science research and experimental development;Development of Human Gene Diagnosis and Therapy Technology;Human stem cell technology development and application;R&D and application of cell technology;Health Consulting Services(Does not include medical services);Information Consulting Service(Not including licensing information consulting services);software development;Blockchain technology related software and services;Technology intermediary service;Computer System Services;Consulting and planning service;New material technology research and development;Information Technology Consulting Services;Network technology service;Biochemical product technology research and development;Conference and Exhibition Services;Sales of Class I Medical Devices;Sales of Class II Medical Devices;Inspection and testing service;medical service;Drug Clinical Trial Services;Class III medical device business;

Hangzhou Adicon Clinical Laboratories, Inc. is a Chinese private company located in Hangzhou that provides healthcare testing services.

Chongqing Paijin Biotechnology Co., Ltd., established on 2013-03-28, Business scope includes general items:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion,Biochemical product technology research and development,Fermentation process optimization technology research and development,Engineering and Technology Research and Experimental Development,Medical Research and Experimental Development(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Bavarian Nordic A/S focuses on the development, manufacturing and commercialization of cancer immunotherapies and vaccines for infectious diseases. It specializes in cancer immunotherapy which includes cancer pipeline, which focuses on therapeutic vaccines for breast, lung, ovarian and prostate cancer. Its products include IMVAMUNE for Ebola, HPV, HBV, and HIV diseases. The company was founded in 1994 and is headquartered in Kvistgaard, Denmark.

The IITB-Monash Research Academy is a graduate research school located in Mumbai, India. It opened in 2008 as a joint venture between the Indian Institute of Technology Bombay and Monash University. Students of the Academy study for a dual PhD from both institutions, spending time in both Australia and India, with supervisors from both IITB and Monash. The establishment of the Academy marks the first time that an Australian university has set up an extensive physical presence in India.

Cell Products of National Engineering Research Center is involved in the study and development of stem cell medicines, regenerative medicine-related tissue engineering products, and cell quality assessment technology. It creates goods and technologies for the industry's research, development, and transformation center for cell products using stem cells for therapeutic applications.

Chengdu Hetong Yichuang Biotechnology Co., Ltd., established on 2018-03-28, Business scope includes research and development of biological reagents;Biotechnology Extension Services;drug development,retail(Did not obtain the relevant administrative license(approval),Do not carry out business activities);Research and development of chemical reagents,Sales(Free of Hazardous Chemicals);Biotechnology R&D,Biotechnology Consulting,biotechnology transfer;software development,Sales;research and development,Sales:cosmetic,Disinfectant;food sales(Did not obtain the relevant administrative license(approval),Do not carry out business activities);Chinese herbal medicine planting;metal products,metallic material(No precious metals),arts and crafts,Jewelry,Agricultural and sideline products,Minerals(Except for special regulations of the state),laboratory equipment,Chemical Products(Free of Hazardous Chemicals),Class I medical device,Class III Medical Devices(Did not obtain the relevant administrative license(approval),Do not carry out business activities)Sales;Class II medical device business;Educational Consulting;Import and export;Domestic trade agent;business inquiries.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments).

Qianshi Biotechnology (Shanghai) Co., Ltd., established on 2019-07-01, Business scope includes general items:Medical Research and Experimental Development;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Research and development of bio-based materials technology;Extraction of marine bioactive substances,purification,Synthesis technology research and development;Remote Health Management Services;Cosmetics Wholesale;Chemical product sales(No licensed chemical products);Disinfectant sales(Free of Hazardous Chemicals);Production of Class I Medical Devices;Sales of Class I Medical Devices;Information Technology Consulting Services;Corporate Headquarters Management.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license) licensed items:Disinfectant production(Free of Hazardous Chemicals);pharmaceutical production.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)